R & D
|
4
|
Resverlogix Corp.
|
Jul 30, 2019 11:12AM
|
Lending Shares
|
4
|
Resverlogix Corp.
|
Jul 29, 2019 11:54AM
|
FOBS
|
5
|
Resverlogix Corp.
|
Jul 27, 2019 11:37PM
|
Re: NLRP3 inhibitors and apabetalone
|
5
|
Resverlogix Corp.
|
Jul 26, 2019 01:32PM
|
Re: NLRP3 inhibitors and apabetalone
|
6
|
Resverlogix Corp.
|
Jul 26, 2019 01:24PM
|
Re: Soliciting a loan to shorters
|
3
|
Resverlogix Corp.
|
Jul 26, 2019 01:03PM
|
Gilead / Galapagos NV
|
1
|
Resverlogix Corp.
|
Jul 15, 2019 10:45AM
|
Re: Insider Selling
|
4
|
Resverlogix Corp.
|
Jul 13, 2019 09:06PM
|
Re: Insider Selling
|
4
|
Resverlogix Corp.
|
Jul 11, 2019 09:17PM
|
Re: Insider Selling
|
|
Resverlogix Corp.
|
Jul 11, 2019 08:44PM
|
31221773
|
|
Resverlogix Corp.
|
Jun 27, 2019 10:51PM
|
AD Link
|
|
Resverlogix Corp.
|
Jun 27, 2019 10:46PM
|
Re: Probability of Phase 3 trial success
|
2
|
Resverlogix Corp.
|
Jun 22, 2019 07:52PM
|
Yawn
|
5
|
Resverlogix Corp.
|
Jun 20, 2019 03:55PM
|
ALP & Biomarker Signatures
|
5
|
Resverlogix Corp.
|
Jun 13, 2019 01:01PM
|
Market Pricing
|
6
|
Resverlogix Corp.
|
Jun 12, 2019 04:41PM
|
# Of Sites
|
|
Resverlogix Corp.
|
Jun 05, 2019 03:26PM
|
Re: Radio Silence
|
1
|
Resverlogix Corp.
|
Jun 03, 2019 04:27PM
|
Re: Last hour.....
|
4
|
Resverlogix Corp.
|
Jun 01, 2019 01:51AM
|
Re: Last hour.....
|
1
|
Resverlogix Corp.
|
May 31, 2019 03:48PM
|